Visterra Inc.
We bring better biologics to life. Biospace Best Place to Work 2024!
Waltham, United States
139 employees
Series C
Total: $125.39M
Biotechnology, Health Care +1
General Information
Waltham, United States
BounceWatch is an independent company data service, not affiliated with Visterra Inc.. To contact Visterra Inc., visit visterrainc.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Visterra Inc. compare?
A PDF of Visterra Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Visterra Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Visterra Inc. on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Visterra Inc.
Business keywords: biologics, biotechnology company, antibody-based therapies, precision medicine, kidney diseases, clinical stage, novel therapies, unmet medical needs, Phase 2 clinical development, partnerships, engineering precision antibodies, disease targets, innovative treatments, drug development, biomedical research
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | $23.60M | 10 |
|
05 Oct 2017 |
| Series C | $23.10M | 6 |
|
01 Jun 2016 |
| Series B | $30.00M | 10 |
|
02 Oct 2014 |
| Series A | $8.10M | 5 |
|
02 Dec 2013 |
| Series A | $26.10M | 5 |
|
09 Nov 2012 |
| Debt Financing | $6.00M | 3 |
|
10 Aug 2010 |
| Seed Round | $3.20M | - |
|
07 Dec 2009 |
| Seed Round | $3.25M | 3 |
|
10 May 2009 |
| Seed Round | $2.04M | 1 |
|
04 Feb 2008 |
Visterra Inc. Alternatives & Competitors
View All Alternatives
Innovative pediatric immunotherapies for Real-life Possibilities
Harnessing the power of microglia to transform treatments for neurodegenerative diseases
Cogent Biosciences
FAQ About Visterra Inc.
Source: BounceWatch company record for Visterra Inc., https://bouncewatch.com/company/visterra-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.
